Edition:
United States

Livzon Pharmaceutical Group Inc (000513.SZ)

000513.SZ on Shenzhen Stock Exchange

50.30CNY
21 Jul 2017
Change (% chg)

¥1.49 (+3.05%)
Prev Close
¥48.81
Open
¥48.81
Day's High
¥50.49
Day's Low
¥48.81
Volume
3,067,084
Avg. Vol
3,206,751
52-wk High
¥52.92
52-wk Low
¥36.12

000513.SZ

Chart for 000513.SZ

About

LIVZON PHARMACEUTICAL GROUP INC. is a China-based company principally engaged in research, development, production and distribution of pharmaceutical products. The Company primarily offers western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. The Company’s... (more)

Overall

Beta: 0.65
Market Cap(Mil.): ¥24,883.48
Shares Outstanding(Mil.): 553.23
Dividend: 0.38
Yield (%): 0.79

Financials

  000513.SZ Industry Sector
P/E (TTM): 31.10 11.87 15.95
EPS (TTM): 1.57 -- --
ROI: 15.21 -9.97 -8.24
ROE: 14.59 -9.81 -7.87

BRIEF-Livzon Pharmaceutical announces net profit attributable for HY ended 30 June 2017

* Preliminary net profit attributable for six months ended 30 June 2017 about rmb 490.9 million-rmb531.8 million versus rmb409.1 million last year Source text for Eikon: Further company coverage:

Jul 11 2017

BRIEF-Livzon Pharma expects H1 net profit to rise 20-30 pct y/y

* Says it expects H1 net profit to rise 20-30 percent y/y to 490.9-531.8 million yuan ($72.20-$78.21 million)

Jul 11 2017

BRIEF-Livzon Pharmaceutical Group elects chairman, vice chairman

* Says board elects Zhu Baoguo as chairman, Tao Desheng as vice chairman

Jun 30 2017

BRIEF-Livzon Pharmaceutical Group to pay FY 2016 annual div on July 7

* Says it will pay FY 2016 dividend to shareholders of record on July 6

Jun 29 2017

BRIEF-Livzon Pharma's unit signs medicine sales contract for 480.6 mln yuan

* Says unit signs medicine sales contract for 480.6 million yuan ($70.61 million)

Jun 01 2017

BRIEF-Livzon Pharmaceutical's Q1 net profit up 19.5 pct y/y

* Says Q1 net profit up 19.5 percent y/y at 275.0 million yuan ($39.90 million)

Apr 27 2017

BRIEF-Livzon Pharma, unit to sell pharma firm, A-share trade to resume

* Says it and unit sign agreement to sell pharma firm for 4.55 billion yuan ($660.67 million)

Apr 19 2017

BRIEF-Livzon Pharmaceutical Group says trading in H shares of company will be halted

* Trading in h shares of company will be halted pending announcement relating to proposed disposal of subsidiary Source text for Eikon: Further company coverage:

Apr 17 2017

BRIEF-Livzon Pharmaceutical's trading in A-shares to halt pending announcement

* Says trading in A-shares to halt from April 14 pending announcement related to asset sales

Apr 13 2017

BRIEF-Livzon Pharmaceutical Group sees Q1 FY 2017 net profit up 17 pct to 25 pct

* Sees Q1 FY 2017 net profit to increase by 17 percent to 25 percent, or to be 269.2 million yuan to 287.6 million yuan

Apr 12 2017

Earnings vs. Estimates